Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2026-02-01 @ 12:06 AM
Study NCT ID:
NCT00064233
Status:
COMPLETED
Last Update Posted:
2020-08-03
First Post:
2003-07-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000310142
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |